April 14, 2021
Video
Adriana Rossi, MD, provides clinical pearls on the management of triple-class refractory multiple myeloma.
April 14, 2021
Video
An expert in multiple myeloma shares her perspective on the significance of recent single-agent approvals for patients with triple-class refractory multiple myeloma and highlights promising combination regimens under investigation.
April 14, 2021
Video
Dr Adrianna Rossi reviews considerations for treatment selection in the triple-class refractory setting in patients with multiple myeloma.
April 14, 2021
Video
Adriana Rossi, MD, describes key clinical trials and their implications for the management of triple-class refractory multiple myeloma.
April 14, 2021
Video
Dr Adriana Rossi reviews the therapeutic options for patients with triple-class refractory multiple myeloma in terms of mechanism of action and safety profile.
April 14, 2021
Video
An expert in multiple myeloma provides insight on the treatment challenges for patients with triple-class refractory disease, particularly after fourth or later lines.